174 related articles for article (PubMed ID: 37552031)
1. Humanized Mouse Models for Immuno-oncology Drug Discovery.
Kumari R; Feuer G; Bourré L
Curr Protoc; 2023 Aug; 3(8):e852. PubMed ID: 37552031
[TBL] [Abstract][Full Text] [Related]
2. Humanized Mice for the Study of Immuno-Oncology.
De La Rochere P; Guil-Luna S; Decaudin D; Azar G; Sidhu SS; Piaggio E
Trends Immunol; 2018 Sep; 39(9):748-763. PubMed ID: 30077656
[TBL] [Abstract][Full Text] [Related]
3. Humanized mouse models for immuno-oncology research.
Chuprin J; Buettner H; Seedhom MO; Greiner DL; Keck JG; Ishikawa F; Shultz LD; Brehm MA
Nat Rev Clin Oncol; 2023 Mar; 20(3):192-206. PubMed ID: 36635480
[TBL] [Abstract][Full Text] [Related]
4. Modeling Tumor Immunology and Immunotherapy in Mice.
Buqué A; Galluzzi L
Trends Cancer; 2018 Sep; 4(9):599-601. PubMed ID: 30149876
[TBL] [Abstract][Full Text] [Related]
5. Techniques for the generation of humanized mouse models for immuno-oncology.
Yu CI; Marches F; Wu TC; Martinek J; Palucka K
Methods Enzymol; 2020; 636():351-368. PubMed ID: 32178826
[TBL] [Abstract][Full Text] [Related]
6. The Development of Next-generation PBMC Humanized Mice for Preclinical Investigation of Cancer Immunotherapeutic Agents.
Morillon YM; Sabzevari A; Schlom J; Greiner JW
Anticancer Res; 2020 Oct; 40(10):5329-5341. PubMed ID: 32988851
[TBL] [Abstract][Full Text] [Related]
7. Modeling the Tumor Microenvironment and Cancer Immunotherapy in Next-Generation Humanized Mice.
Chen A; Neuwirth I; Herndler-Brandstetter D
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296949
[TBL] [Abstract][Full Text] [Related]
8. Autologous humanized PDX modeling for immuno-oncology recapitulates features of the human tumor microenvironment.
Chiorazzi M; Martinek J; Krasnick B; Zheng Y; Robbins KJ; Qu R; Kaufmann G; Skidmore Z; Juric M; Henze LA; Brösecke F; Adonyi A; Zhao J; Shan L; Sefik E; Mudd J; Bi Y; Goedegebuure SP; Griffith M; Griffith O; Oyedeji A; Fertuzinhos S; Garcia-Milian R; Boffa D; Detterbeck F; Dhanasopon A; Blasberg J; Judson B; Gettinger S; Politi K; Kluger Y; Palucka K; Fields RC; Flavell RA
J Immunother Cancer; 2023 Jul; 11(7):. PubMed ID: 37487666
[TBL] [Abstract][Full Text] [Related]
9. In Vivo Modeling of Tumor Heterogeneity for Immuno-Oncology Studies: Failures, Improvements, and Hopes.
DiMarco AV; Maddalo D
Curr Protoc; 2022 Mar; 2(3):e377. PubMed ID: 35255200
[TBL] [Abstract][Full Text] [Related]
10. Promising preclinical platform for evaluation of immuno-oncology drugs using Hu-PBL-NSG lung cancer models.
Pyo KH; Kim JH; Lee JM; Kim SE; Cho JS; Lim SM; Cho BC
Lung Cancer; 2019 Jan; 127():112-121. PubMed ID: 30642538
[TBL] [Abstract][Full Text] [Related]
11. Mouse models for immuno-oncology.
Bosenberg M; Liu ET; Yu CI; Palucka K
Trends Cancer; 2023 Jul; 9(7):578-590. PubMed ID: 37087398
[TBL] [Abstract][Full Text] [Related]
12. A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research.
Li Z; Yang X; Zhang Y; Yang X; Cui X; Zhang Y; Gong W; Bai H; Liu N; Tang Z; Guo M; Li K; Zhang T; Wang L; Song X
J Vis Exp; 2019 Aug; (150):. PubMed ID: 31475974
[TBL] [Abstract][Full Text] [Related]
13. Creation of PDX-Bearing Humanized Mice to Study Immuno-oncology.
Yao LC; Aryee KE; Cheng M; Kaur P; Keck JG; Brehm MA
Methods Mol Biol; 2019; 1953():241-252. PubMed ID: 30912026
[TBL] [Abstract][Full Text] [Related]
14. Establishment of Humanized Mice from Peripheral Blood Mononuclear Cells or Cord Blood CD34+ Hematopoietic Stem Cells for Immune-Oncology Studies Evaluating New Therapeutic Agents.
Verma B; Wesa A
Curr Protoc Pharmacol; 2020 Jun; 89(1):e77. PubMed ID: 32453514
[TBL] [Abstract][Full Text] [Related]
15. Development and Applications of Patient-Derived Xenograft Models in Humanized Mice for Oncology and Immune-Oncology Drug Discovery.
Verma B; Ritchie M; Mancini M
Curr Protoc Pharmacol; 2017 Sep; 78():14.41.1-14.41.12. PubMed ID: 28892144
[TBL] [Abstract][Full Text] [Related]
16. [Development of the next generation humanized mouse for drug discovery].
Ito R
Nihon Yakurigaku Zasshi; 2018; 151(4):160-165. PubMed ID: 29628464
[TBL] [Abstract][Full Text] [Related]
17. Experimental animal modeling for immuno-oncology.
Li QX; Feuer G; Ouyang X; An X
Pharmacol Ther; 2017 May; 173():34-46. PubMed ID: 28167217
[TBL] [Abstract][Full Text] [Related]
18. Recent Advancements and Applications of Human Immune System Mice in Preclinical Immuno-Oncology.
Curran M; Mairesse M; Matas-Céspedes A; Bareham B; Pellegrini G; Liaunardy A; Powell E; Sargeant R; Cuomo E; Stebbings R; Betts CJ; Saeb-Parsy K
Toxicol Pathol; 2020 Feb; 48(2):302-316. PubMed ID: 31847725
[TBL] [Abstract][Full Text] [Related]
19. Faithful preclinical mouse models for better translation to bedside in the field of immuno-oncology.
Saito R; Kobayashi T; Kashima S; Matsumoto K; Ogawa O
Int J Clin Oncol; 2020 May; 25(5):831-841. PubMed ID: 31407168
[TBL] [Abstract][Full Text] [Related]
20. Translational and Clinical Relevance of PDX-Derived Organoid Models in Oncology Drug Discovery and Development.
Kumari R; Xu X; Li HQ
Curr Protoc; 2022 Jul; 2(7):e431. PubMed ID: 35789132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
